Edwards Lifesciences CFO exercises 19,830 Performance Rights
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Edwards Lifesciences Corp Chief Financial Officer Scott B. Ullem reported compensation-related equity transactions tied to performance-based restricted stock units. On May 11, 2026, he exercised 19,830 Performance Rights into the same number of common shares following the Compensation and Governance Committee’s decision that 167.70% of the target units would vest.
To cover tax obligations, 11,004 common shares were disposed of through a tax-withholding transaction at $79.96 per share, rather than via an open-market sale. After these transactions, he directly holds 46,740 common shares and indirectly holds 266,318 common shares through a trust. The Performance Rights exercised in this filing are now fully converted, with no remaining derivative position from this award.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Performance Rights | 19,830 | $0.00 | $0.00 |
| Exercise | Common Stock | 19,830 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 11,004 | $79.96 | $880K |
| Holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4.
- F2. These Performance Rights expire on May 10, 2030.
Key Figures
Key Terms
restricted stock units financial
performance-based vesting requirements financial
Performance Rights financial
tax-withholding disposition financial
Compensation and Governance Committee financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Edwards Lifesciences (EW) CFO Scott Ullem report in this Form 4?
Was the Edwards Lifesciences (EW) CFO’s Form 4 a stock sale on the open market?
What performance outcome triggered the Edwards Lifesciences (EW) Performance Rights vesting?
What are the Edwards Lifesciences (EW) Performance Rights mentioned in the Form 4?
When do the Edwards Lifesciences (EW) Performance Rights reported here expire?
AI-generated analysis. How Rhea-AI works. Not financial advice.